Because it is impossible to design a prescription drug that provides the desired health benefits with zero risk of harm, courts have long held that manufacturers of prescription drugs are not strictly ...
While the European Union (EU) Parliament’s study points out the benefits of having a single point of liability within the AI chain, one has to wonder whether this runs the risk of oversimplifying risk ...
Paul was a Senior Legal Research Fellow in the Meese Center for Legal and Judicial Studies at The Heritage Foundation. Not everyone agrees with the validity of the Supreme Court’s approach to ...